A complete medical history, including cardiovascular risk factors, thyroid disease, pancreatitis history, and current medications, is essential before considering GLP-1 agonist therapy
And while buzzy weight loss drugs like Ozempic, Mounjaro, and Wegovy have relied on weekly injections, new oral medication pills made with the same active ingredient, semaglutide, could soon enter the market, once again revolutionizing access to these medications
doi:10.1038/nrn3880 167
This innovative therapy may redefine traditional health care, providing natural and effective solutions.
Not for human dosing, injection, or ingestion